Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Novel use of computed tomography-derived body composition to facilitate risk assessment in patients with bladder cancer.

BACKGROUND Comprehensive geriatric assessments (CGA) inform risk stratification in bladder cancer (BC) care but are time- and resource-intensive. PURPOSE To investigate whether body composition analysis (BCA) on computed tomography (CT) is associated with CGA. METHODS Patients with BC (any stage) were enrolled in a...

L. Mantz, Alex Zhu, Nathaniel D. Mercaldo et al. · 0 citations
Open access Sep 2026

Patient-reported outcomes as non-muscle-invasive bladder cancer clinical trial endpoints.

OBJECTIVE To evaluate the frequency at which patient-reported outcomes (PROs) are incorporated as nonmuscle-invasive bladder cancer (NMIBC) clinical trial endpoints. PATIENTS AND METHODS Interventional trials limited to patients with NMIBC were queried from clinicaltrials.gov from 1994 to 2025 (start of trial). Obser...

Kimberly Toumazos, Spencer Bell, Katelyn A. Spencer et al. · 0 citations
Sep 2026

Impact of Age on Outcomes in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Real-World TriNetX Analysis From the Global Society of Rare Genitourinary Tumors (GSRGT).

BACKGROUND Malignancies arising in young adults often exhibit biological and clinical behaviors distinct from those in older patients. Limited data exist on the prognostic impact of age in metastatic non-clear cell renal cell carcinoma (mnccRCC). This study compared survival outcomes by age using the large-scale TriNet...

A. Cigliola, Nazli Dizman, C. Mercinelli et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.